Therefore, we tried to preliminarily explore whether might be sex differences in survival benefits from ATRX mutation through comparing the differences of prognosis outcomes from ATRX mutation between female and male patients across various cancer types in the whole cohort. The gene discussed is ATRX; the disease is cancer.